Hybridoma clones and monoclonal antibodies to fibroblast growth factor 4
US9611319B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 12, 2014 |
| Grant date | Apr 4, 2017 |
| Priority date | — |
| Expiry date | Mar 12, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N5/163
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention is directed to a monoclonal antibody that recognizes human FGFR4 in its native form. The invention is also directed to a hybridoma cell line that produces the monoclonal antibody and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.